marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Pluristem Therapeutics Cash Flow 2011-2024 | PSTI
Annual Cash Flow Pluristem Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-18 M | -22.9 M | -36.5 M | -30.9 M | -26.4 M | -29.5 M | -21.4 M | -21.6 M | -18.5 M | -20.6 M | - | -16.9 M | -3.28 M | -5.76 M |
Depreciation & Amortization |
253 K | 362 K | 1.05 M | 1.37 M | 1.57 M | 1.96 M | 2.02 M | 2.18 M | 2.15 M | 2.07 M | 1.9 M | 1.03 M | 435 K | 312 K |
Accounts Payables |
964 K | 1.81 M | 1.78 M | 2.53 M | - | 2.28 M | 3.26 M | 1.97 M | 2.7 M | 3.27 M | 3.46 M | 2.84 M | 1.37 M | - |
Accounts Receivables |
- | - | - | 19 K | - | - | 58 K | 1.04 M | 2.23 M | 1.69 M | 2.26 M | - | 135 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Pluristem Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-4.06 M | - | - | -5.86 M | - | - | - | -7.61 M | -13.9 M | - | - | -8.79 M | -18.7 M | - | - | -6.14 M | -14 M | -6.14 M | - | -7.24 M | -13.5 M | -7.24 M | - | -8.51 M | - | - | - | -5.19 M | -10 M | -5.19 M | - | -3.92 M | - | - | - | - | - | - | - | - | - | - | - | -5.1 M | - | - | - | -3.52 M | -6.89 K | -3.52 M | - | 3.46 M | 174 K | 3.46 M |
Depreciation & Amortization |
65 K | - | - | 67 K | - | - | - | 100 K | 197 K | - | - | 337 K | 664 K | - | - | 347 K | 695 K | 347 K | - | 468 K | 853 K | 468 K | - | 503 K | - | - | - | 515 K | 1.02 M | 515 K | - | 558 K | 1.11 M | 558 K | - | 497 K | 1.03 M | 497 K | - | 498 K | 1 M | 498 K | - | 461 K | 937 K | 461 K | - | 130 K | 276 | 130 K | - | 97 K | 199 K | 97 K |
Accounts Payables |
1.13 M | 964 K | 1.1 M | 973 K | 1.81 M | 1.45 M | 1.26 M | 1.33 M | 1.78 M | 2.39 M | 2.61 M | 2.3 M | 2.53 M | 2.53 M | 2.85 M | 1.8 M | 1.97 M | 1.81 M | 1.86 M | 2.89 M | 2.28 M | 2.28 M | 2.07 M | 2.13 M | 3.26 M | 1.92 M | 1.81 M | 1.55 M | 1.97 M | 1.97 M | 2.78 M | 2.29 M | 2.7 M | 2.7 M | 1.84 M | 1.5 M | 3.27 M | 3.27 M | 2.52 M | 2.42 M | 3.46 M | 3.46 M | 2.71 M | 2.88 M | 2.84 M | 2.84 M | 3.4 K | 1.7 M | 1.37 K | 1.37 M | 1.17 M | 1.08 M | 1.18 M | 1.18 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 285 K | 82 K | 37 K | 58 K | 596 K | 172 K | 25 K | 1.04 M | 1.04 M | 287 K | 459 K | 2.23 M | 2.23 M | 150 K | 419 K | 1.69 M | 1.69 M | 158 K | 451 K | 2.26 M | 2.26 M | - | - | 273 K | 1.28 M | 1.7 K | 1.67 M | 383 | 383 K | 266 K | 225 K | 154 K | 154 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency